Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymetrix Inc.
Affymetrix Founder and CEO Announces Succession Plan
November 7th, 2008
Affymetrix Inc. (Nasdaq:AFFX) announced that Stephen P.A. Fodor, Ph.D., founder, chairman and CEO, will begin to transfer his CEO responsibilities to Kevin M. King, president of Affymetrix. Assuming the new role of full-time executive chairman, Dr. Fodor will identify and advance new platform technologies and explore new market opportunities for the company. Mr. King will become CEO and a member of the Board of Directors on January 1, 2009. Dr. Fodor founded Affymetrix to commercialize the high-density arrays that he and his colleagues developed in the late 1980s. The company pioneered transforming paradigm shifts in modern molecular biology. It has opened new markets...
Source: Health Business Week (2008-11-07)
|
